These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 20625573)

  • 41. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI; Huhtaniemi I
    Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testosterone and men's quality of life.
    Moncada I
    Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone replacement therapy and longevity.
    Comhaire F
    Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male.
    Morales A; Lunenfeld B;
    Aging Male; 2002 Jun; 5(2):74-86. PubMed ID: 12198738
    [No Abstract]   [Full Text] [Related]  

  • 46. A new testosterone gel (fortesta) for hypogonadism.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
    Dobs AS
    Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Case report: treatment of androgen deficiency in the aging male.
    Hernandez A; Baum N
    Postgrad Med; 2008 Nov; 120(4):73-7. PubMed ID: 19020368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypogonadism in elderly men--what to do until the evidence comes.
    Snyder PJ
    N Engl J Med; 2004 Jan; 350(5):440-2. PubMed ID: 14749451
    [No Abstract]   [Full Text] [Related]  

  • 50. Testosterone replacement in older men and women.
    Morley JE
    J Gend Specif Med; 2001; 4(2):49-53. PubMed ID: 11480098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
    Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M; Lipshultz LI
    Urol Clin North Am; 2007 Nov; 34(4):549-53, vi. PubMed ID: 17983894
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypogonadism in chronic obstructive pulmonary disease: incidence and effects.
    Balasubramanian V; Naing S
    Curr Opin Pulm Med; 2012 Mar; 18(2):112-7. PubMed ID: 22234275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.
    Lunenfeld B; Mskhalaya G; Zitzmann M; Arver S; Kalinchenko S; Tishova Y; Morgentaler A
    Aging Male; 2015 Mar; 18(1):5-15. PubMed ID: 25657080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testosterone replacement therapy for late-onset hypogonadism: current trends in Korea.
    Ko YH; Kim JJ
    Asian J Androl; 2011 Jul; 13(4):563-8. PubMed ID: 21572448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testosterone replacement therapy in prostate cancer patients: is it safe?
    Umbas R; Sugiono M
    Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 'What should I do with a 60-year old man with a slightly low serum total testosterone concentration and normal levels of serum gonadotrophins'?
    Hugh Jones T
    Clin Endocrinol (Oxf); 2010 May; 72(5):584-8. PubMed ID: 19878210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone replacement therapy after primary treatment for prostate cancer.
    Agarwal PK; Oefelein MG
    J Urol; 2005 Feb; 173(2):533-6. PubMed ID: 15643240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal therapy of male hypogonadism.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hormone replacement therapy in men: practical aspects].
    Gamidov SI; Shcherbakov DV; Tazhetdinov OKh; Pavlovichev AA; Iremashvili VV
    Urologiia; 2011; (4):68, 70-3. PubMed ID: 22066247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.